Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

326
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
326

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Analysis of Aggressive Multifocal Cutaneous Squamous Cell Carcinoma Associated with a Germline COL6A3 Truncating Variant: A Case Report.

Diagnostics (Basel, Switzerland)·2026
Same author

Ligand-mediated formation of amphiphilic silver nanoclusters: synthesis, redox properties, and activity against clinically relevant bacteria.

Journal of materials chemistry. B·2026
Same author

DNA-hybridization on gold nanospheres: a dual-fluorescence investigation of surface loading and strand length effects.

Journal of biomedical optics·2026
Same author

Investigating the reproducibility and repeatability of commercial SERS substrates using a new methodological approach.

Analytical methods : advancing methods and applications·2026
Same author

Tunable gelatin-coated biosynthesized gold nanotriangles: Thermoplasmonic performance and in vitro therapeutic potential via on-demand visible-NIR LED activation.

Colloids and surfaces. B, Biointerfaces·2026
Same author

Recent Advances in Plasmon-Assisted Optical Sensing of Inflammatory Biomarkers.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026

Related Experiment Video

Updated: Sep 3, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
09:23

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

6.4K

Cardiac Troponin Biosensor Designs: Current Developments and Remaining Challenges.

Andreea Campu1, Ilinca Muresan1, Ana-Maria Craciun1

  • 1Nanobiophotonics and Laser Microspectroscopy Center, Interdisciplinary Research Institute in Bio-Nano-Sciences, Babes-Bolyai University, Treboniu Laurian No. 42, 400271 Cluj-Napoca, Romania.

International Journal of Molecular Sciences
|July 27, 2022
PubMed
Summary

Diagnosing acute myocardial infarction (AMI) requires better methods than ECG. This review explores advancements in biosensors for rapid, on-site detection of cardiac troponin I (cTnI) and cardiac troponin T (cTnT) biomarkers.

Keywords:
cardiac troponin biomarkerselectrochemical detectionfluorescence detectionsurface enhanced Raman spectroscopysurface plasmon resonance

More Related Videos

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
13:42

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Published on: September 19, 2017

11.9K
Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

3.4K

Related Experiment Videos

Last Updated: Sep 3, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
09:23

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

6.4K
Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
13:42

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Published on: September 19, 2017

11.9K
Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

3.4K

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Diagnostics
  • Biomarker Detection

Background:

  • Acute myocardial infarction (AMI) is a leading cause of mortality globally.
  • Current diagnostic methods like electrocardiography (ECG) have limitations in sensitivity and specificity.
  • Cardiac troponin I (cTnI) and cardiac troponin T (cTnT) are superior biomarkers for detecting myocardial damage.

Purpose of the Study:

  • To review breakthroughs in biosensor development for cTnI and cTnT detection.
  • To highlight progress and challenges in creating rapid, on-site diagnostic tools.
  • To facilitate early diagnosis and treatment of cardiovascular diseases.

Main Methods:

  • Review of recent literature on biosensor designs for cTnI and cTnT.
  • Analysis of analytical tools for biomarker quantification.
  • Discussion of technological advancements towards portable testing chips.

Main Results:

  • Significant progress in developing specific and sensitive biosensors for cTnI and cTnT.
  • Emerging analytical tools show promise for efficient biomarker measurement.
  • Development of strategies for cost-efficient, portable diagnostic devices.

Conclusions:

  • Biosensors offer a promising alternative to traditional methods for AMI diagnosis.
  • Further development is needed to achieve simple, cheap, and portable testing chips.
  • On-site detection of cTnI/cTnT can enable timely, life-saving interventions.